This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
The FDA is also investigating reported side effects of aspiration.
Only 2018 featured a higher number of drug approvals.
However, about 17 percent of individuals prescribed a placebo kept about 80 percent of their original weight loss, a new trial shows.
As childhood obesity rates surge globally, pharma giants test weight loss drugs on kids despite safety concerns over side effects and long-term health impacts.
The U.S. Food and Drug Administration has urged online vendors to stop selling unapproved semaglutide and tirzepatide drugs due to public health concerns.
